HBK Sorce Advisory’s Imunon IMNN Stock Holding History

HBK Sorce Advisory’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-59	Closed	-$6K	–	584
2021 Q4	$6K	Hold	59	–	–	﹤0.01%	595
2021 Q3	$11K	Hold	59	–	–	﹤0.01%	587
2021 Q2	$15K	Hold	59	–	–	﹤0.01%	589
2021 Q1	$16K	Buy	+59	New	+$19.8K	﹤0.01%	543

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

HBK Sorce Advisory's IMNN Position: Q1 2022 in Review

HBK Sorce Advisory sold out of Imunon (IMNN) in Q1 2022, closing a stake of 59 shares — an estimated $6K sold.

HBK Sorce Advisory first reported a position in IMNN in Q1 2021 and held it in 4 quarters. The position peaked at $16K in Q1 2021. 23 funds tracked by Wall St. Rank hold IMNN as of Q1 2022.

HBK Sorce Advisory reported no remaining Imunon position as of Q1 2022 after selling out during the quarter.
HBK Sorce Advisory sold 59 Imunon shares in Q1 2022, an estimated $6K.
HBK Sorce Advisory first reported a position in Imunon in Q1 2021 and held it in 4 quarters.
HBK Sorce Advisory's Imunon position peaked at $16K in Q1 2021.
23 funds tracked by Wall St. Rank held Imunon as of Q1 2022.

Based on HBK Sorce Advisory's 13F filing for Q1 2022, filed 13 May 2022.